Market Overview

From Earlier: MKM Partners Downgrades Acorda Therapeutics, Inc. to Neutral

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for ACOR

DateFirmActionFromTo
Dec 2014Goldman SachsInitiates Coverage onNeutral
Oct 2014CitigroupMaintainsNeutral
Oct 2014FBR CapitalMaintainsOutperform

View More Analyst Ratings for ACOR
View the Latest Analyst Ratings

Posted-In: News Downgrades Analyst Ratings

 

Related Articles (ACOR)

Around the Web, We're Loving...

Get Benzinga's Newsletters